Chinese scientists to pioneer first human CRISPR trial

Nature. 2016 Jul 28;535(7613):476-7. doi: 10.1038/nature.2016.20302.
No abstract available

Publication types

  • News

MeSH terms

  • Animals
  • CRISPR-Cas Systems / genetics*
  • Carcinoma, Non-Small-Cell Lung / immunology*
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • China
  • Clinical Trials, Phase I as Topic*
  • Embryo Research
  • Gene Knockout Techniques
  • Genetic Engineering*
  • HIV Infections / therapy
  • Haplorhini / genetics
  • Humans
  • Immunotherapy / methods
  • Lung Neoplasms / immunology*
  • Lung Neoplasms / therapy*
  • National Institutes of Health (U.S.)
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors
  • Programmed Cell Death 1 Receptor / deficiency
  • Programmed Cell Death 1 Receptor / genetics
  • Programmed Cell Death 1 Receptor / immunology
  • Reproducibility of Results
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • United States
  • United States Food and Drug Administration

Substances

  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor